Oxford University and Serum Institute Partner on Next-Generation R78C Malaria Vaccine
The University of Oxford and the Serum Institute of India have joined hands to develop R78C, a next-generation malaria vaccine. The candidate targets Plasmodium falciparum, the parasite species responsible for the most s...